One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases
Wesley C. Van Voorhis, Matthew A. Hulverson, Ryan Choi, Wenlin Huang, Samuel L.M. Arnold, Deborah A. Schaefer, Dana P. Betzer, Rama Subba Rao Vidadala, Sangun Lee, Grant R. Whitman, Lynn K. Barrett, Dustin J. Maly, Michael W. Riggs, Erkang Fan, Thomas J. Kennedy, Saul Tzipori, J. Stone Doggett, Pablo Winzer, Nicoleta Anghel, Dennis Imhof, Joachim Müller, Andrew Hemphill, Ignacio Ferre, Roberto Sánchez-Sánchez, Luis Miguel Ortega‐Mora, Kayode K. Ojo
Topics & Concepts
Neospora caninumCryptosporidium parvumCryptosporidiumNeosporaToxoplasmosisApicomplexaToxoplasma gondiiBiologyLivestockVirologyDrug developmentParasitic diseaseDrugImmunologyProtozoal diseaseMedicineMicrobiologyPharmacologyDiseaseMalariaInternal medicineFecesEcologyAntibodyParasitic Infections and DiagnosticsToxoplasma gondii Research StudiesCoccidia and coccidiosis research